Correlation Between Shuttle Pharmaceuticals and Organogenesis Holdings
Can any of the company-specific risk be diversified away by investing in both Shuttle Pharmaceuticals and Organogenesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shuttle Pharmaceuticals and Organogenesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shuttle Pharmaceuticals and Organogenesis Holdings, you can compare the effects of market volatilities on Shuttle Pharmaceuticals and Organogenesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shuttle Pharmaceuticals with a short position of Organogenesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shuttle Pharmaceuticals and Organogenesis Holdings.
Diversification Opportunities for Shuttle Pharmaceuticals and Organogenesis Holdings
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Shuttle and Organogenesis is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Shuttle Pharmaceuticals and Organogenesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organogenesis Holdings and Shuttle Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shuttle Pharmaceuticals are associated (or correlated) with Organogenesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organogenesis Holdings has no effect on the direction of Shuttle Pharmaceuticals i.e., Shuttle Pharmaceuticals and Organogenesis Holdings go up and down completely randomly.
Pair Corralation between Shuttle Pharmaceuticals and Organogenesis Holdings
Given the investment horizon of 90 days Shuttle Pharmaceuticals is expected to under-perform the Organogenesis Holdings. In addition to that, Shuttle Pharmaceuticals is 1.18 times more volatile than Organogenesis Holdings. It trades about -0.07 of its total potential returns per unit of risk. Organogenesis Holdings is currently generating about 0.04 per unit of volatility. If you would invest 265.00 in Organogenesis Holdings on August 28, 2024 and sell it today you would earn a total of 139.00 from holding Organogenesis Holdings or generate 52.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Shuttle Pharmaceuticals vs. Organogenesis Holdings
Performance |
| Timeline |
| Shuttle Pharmaceuticals |
| Organogenesis Holdings |
Shuttle Pharmaceuticals and Organogenesis Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Shuttle Pharmaceuticals and Organogenesis Holdings
The main advantage of trading using opposite Shuttle Pharmaceuticals and Organogenesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shuttle Pharmaceuticals position performs unexpectedly, Organogenesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will offset losses from the drop in Organogenesis Holdings' long position.| Shuttle Pharmaceuticals vs. Lifecore Biomedical | Shuttle Pharmaceuticals vs. Catalent | Shuttle Pharmaceuticals vs. Tilray Inc | Shuttle Pharmaceuticals vs. Organogenesis Holdings |
| Organogenesis Holdings vs. Shuttle Pharmaceuticals | Organogenesis Holdings vs. Lifecore Biomedical | Organogenesis Holdings vs. Redhill Biopharma | Organogenesis Holdings vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |